XY7D.DE vs. GN0M.DE
XY7D.DE (Global X S&P 500 Covered Call UCITS ETF Inc) and GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) are both exchange-traded funds - XY7D.DE is a S&P 500 fund tracking the Cboe S&P 500 BuyWrite 15% WHT, while GN0M.DE is a Health & Biotech Equities fund tracking the Solactive Genomics. Both are passively managed. Over the past year, XY7D.DE returned 16.66% vs 69.41% for GN0M.DE. At a 0.31 correlation, their price movements are largely independent. XY7D.DE charges 0.45%/yr vs 0.50%/yr for GN0M.DE.
Performance
XY7D.DE vs. GN0M.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XY7D.DE achieves a 8.64% return, which is significantly lower than GN0M.DE's 21.92% return.
XY7D.DE
- 1D
- 0.00%
- 1M
- 2.62%
- YTD
- 8.64%
- 6M
- 9.35%
- 1Y
- 16.66%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GN0M.DE
- 1D
- 0.00%
- 1M
- 17.82%
- YTD
- 21.92%
- 6M
- 19.50%
- 1Y
- 69.41%
- 3Y*
- 2.84%
- 5Y*
- —
- 10Y*
- —
XY7D.DE vs. GN0M.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
XY7D.DE Global X S&P 500 Covered Call UCITS ETF Inc | 8.64% | -5.34% | 23.62% | -8.57% |
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 21.92% | 5.67% | -12.40% | -3.31% |
Correlation
The correlation between XY7D.DE and GN0M.DE is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jul 11, 2023 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XY7D.DE vs. GN0M.DE — Risk / Return Rank
XY7D.DE
GN0M.DE
XY7D.DE vs. GN0M.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X S&P 500 Covered Call UCITS ETF Inc (XY7D.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XY7D.DE | GN0M.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.60 | ||
| Sortino ratioReturn per unit of downside risk | -0.67 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.39 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 4.32 | 4.18 | +0.14 |
| Martin ratioReturn relative to average drawdown | 12.52 | 10.59 | +1.93 |
Loading charts...
Drawdowns
XY7D.DE vs. GN0M.DE - Drawdown Comparison
The maximum XY7D.DE drawdown since its inception was -20.79%, smaller than the maximum GN0M.DE drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for XY7D.DE and GN0M.DE.
Loading charts...
Drawdown Indicators
| XY7D.DE | GN0M.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -20.79% | -67.19% | +46.40% |
Max Drawdown (1Y)Largest decline over 1 year | -3.87% | -16.68% | +12.81% |
Max Drawdown (3Y)Largest decline over 3 years | — | -45.68% | — |
Current DrawdownCurrent decline from peak | -1.33% | -36.37% | +35.04% |
Average DrawdownAverage peak-to-trough decline | -7.13% | -43.06% | +35.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.34% | 6.58% | -5.24% |
Volatility
XY7D.DE vs. GN0M.DE - Volatility Comparison
The current volatility for Global X S&P 500 Covered Call UCITS ETF Inc (XY7D.DE) is 2.94%, while Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a volatility of 9.66%. This indicates that XY7D.DE experiences smaller price fluctuations and is considered to be less risky than GN0M.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XY7D.DE | GN0M.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.94% | 9.66% | -6.72% |
Volatility (6M)Calculated over the trailing 6-month period | 6.53% | 20.37% | -13.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 8.89% | 28.15% | -19.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.51% | 31.45% | -17.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.51% | 31.45% | -17.94% |
XY7D.DE vs. GN0M.DE - Expense Ratio Comparison
XY7D.DE has a 0.45% expense ratio, which is lower than GN0M.DE's 0.50% expense ratio.
Dividends
XY7D.DE vs. GN0M.DE - Dividend Comparison
XY7D.DE's dividend yield for the trailing twelve months is around 8.32%, while GN0M.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% |
XY7D.DE Global X S&P 500 Covered Call UCITS ETF Inc | 8.32% | 9.21% | 6.13% | 3.99% |
Frequently Asked Questions
XY7D.DE and GN0M.DE have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XY7D.DE is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XY7D.DE is cheaper with a 0.45% expense ratio, compared with 0.50% for GN0M.DE.
XY7D.DE is categorized as S&P 500, while GN0M.DE is Health & Biotech Equities. XY7D.DE tracks Cboe S&P 500 BuyWrite 15% WHT, while GN0M.DE tracks Solactive Genomics. Their fees differ too: 0.45% for XY7D.DE and 0.50% for GN0M.DE.
Find the right allocation for XY7D.DE and GN0M.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer